Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
ESP Block vs Wound Infiltration for Laminectomy
NCT05271331Recruiting
- Sponsor
- Università di Padova
- Start
- May 2022
- Primary completion
- May 2026
- Modality
- Targeted Liposomes, Stealth (PEGylated) Liposomes, Conventional Liposomes
- Countries
- 1
01
Overview
Randomised, double-blind trial of ropivacaine hydrochloride liposomal suspension injection in postoperative pain (2 arms), sponsored by Università di Padova. Primary endpoint: Tramadol consumption at 24 hours. Started May 2022; status: recruiting.
02
Drugs
ropivacaine hydrochloride liposomal suspension injection
03
Conditions
postoperative pain
Beyond the preview
Go deeper on NCT05271331.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT05271331.